Camden National director receives 919-share stock grant

Camden National Corp director Raina Maxwell received a stock grant as part of board compensation.

Rhea-AI Filing Summary

Camden National Corp director Raina Maxwell received a stock grant as part of board compensation. On the grant date, Maxwell acquired 919 shares of Common Stock under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment. The shares vested immediately and carried no purchase price to the director, reflecting a compensation award rather than a market purchase.

After this grant and additional dividend reinvestments, Maxwell now directly holds 3,753.818 shares, including 24.132 shares accumulated since the last filing through the company's dividend reinvestment program.

Insider Trade Summary

Grant/Award: 919 shares

Grant/Award 1 txn

Insider Maxwell Raina

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	919	$0.00	$0.00

Holdings After Transaction: Common Stock — 3,753.818 shares (Direct)

Footnotes (2)

1. F1. Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A. These shares vested immediately on the date of the grant.
2. F2. Consists of 24.132 shares acquired since the last filing as a result of participation in the Company's dividend reinvestment program.

Key Figures

Stock grant size: 919 shares Post-transaction holdings: 3,753.818 shares Dividend reinvestment accumulation: 24.132 shares +2 more

5 metrics

Stock grant size 919 shares Common Stock granted to director as compensation

Post-transaction holdings 3,753.818 shares Director’s direct Common Stock holdings after grant

Dividend reinvestment accumulation 24.132 shares Shares acquired since last filing via dividend reinvestment

Transaction price per share $0.0000 Indicates compensatory grant with no cash paid by director

Transaction date 2026-06-01 Grant date for the 919-share award

Key Terms

Independent Directors' Equity Compensation Program, 2022 Equity and Incentive Plan and Amendment, dividend reinvestment program, Grant, award, or other acquisition

4 terms

Independent Directors' Equity Compensation Program financial

"Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment"

2022 Equity and Incentive Plan and Amendment financial

"a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A"

dividend reinvestment program financial

"Consists of 24.132 shares acquired since the last filing as a result of participation in the Company's dividend reinvestment program"

A dividend reinvestment program lets investors automatically use cash dividends to buy more shares of the same company instead of taking the money as cash. Think of it like an automatic savings plan that turns small payouts into additional ownership, often including fractional shares, which can speed up compound growth and reduce the need for manual buying decisions — a convenience that can boost long-term returns for shareholders.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Camden National (CAC) director Raina Maxwell report?

Director Raina Maxwell reported receiving a grant of 919 shares of Camden National Common Stock. The award was made under the Independent Directors' Equity Compensation Program and vested immediately, reflecting non-cash board compensation rather than an open-market stock purchase.

Was the Camden National (CAC) stock grant to Raina Maxwell an open-market purchase?

No. The 919 shares reported for Raina Maxwell were granted as compensation under the Independent Directors' Equity Compensation Program. The filing shows a zero dollar price, meaning Maxwell did not buy the shares in the market but received them as an equity award.

How many Camden National (CAC) shares does Raina Maxwell hold after this Form 4?

Following the reported grant, Raina Maxwell directly holds 3,753.818 shares of Camden National Common Stock. This total includes the new 919-share award and 24.132 shares accumulated since the last filing through participation in the company’s dividend reinvestment program.

What is the Independent Directors' Equity Compensation Program at Camden National (CAC)?

The Independent Directors' Equity Compensation Program is part of Camden National’s 2022 Equity and Incentive Plan and Amendment. It grants Common Stock to non-employee directors as part of their compensation, with awards like Maxwell’s 919 shares vesting immediately on the grant date.

How did dividend reinvestment affect Raina Maxwell’s Camden National (CAC) holdings?

The filing notes that 24.132 shares were acquired since the last report through Camden National’s dividend reinvestment program. This means cash dividends on existing holdings were automatically used to buy additional shares, modestly increasing Maxwell’s direct ownership over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maxwell Raina

(Last) (First) (Middle)

2 ELM STREET

P.O. BOX 310

(Street)

CAMDEN MAINE 04843

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		A		919	A	$0(1)	3,753.818(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment; therefore, price is N/A. These shares vested immediately on the date of the grant.

2. Consists of 24.132 shares acquired since the last filing as a result of participation in the Company's dividend reinvestment program.

Remarks:

	Christopher G. Hutchinson, POA	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)